Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus XR vs. Prograf in Stable Kidney Transplant Patients
NCT00817206Phase 3Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 3 trial of Envarsus XR in kidney transplant rejection, sponsored by Veloxis Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
Envarsus XR
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00817206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00817206.